Holen Sie sich die Stockscreener-App
7.81
9.82%
-0.85
Handel nachbörslich:
8.27
0.46
+5.89%
Schlusskurs vom Vortag:
$8.66
Offen:
$8.57
24-Stunden-Volumen:
755.24K
Relative Volume:
0.88
Marktkapitalisierung:
$461.37M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-153.16M
KGV:
-2.1165
EPS:
-3.69
Netto-Cashflow:
$-134.48M
1W Leistung:
-3.10%
1M Leistung:
+32.37%
6M Leistung:
-11.15%
1J Leistung:
-50.51%
1-Tages-Spanne:
$7.76
$8.77
1-Wochen-Bereich:
$7.55
$8.7796
52-Wochen-Spanne:
$5.68
$17.50
Cullinan Therapeutics Inc Stock (CGEM) Company Profile
Firmenname
Cullinan Therapeutics Inc
Sektor
Branche
Telefon
617-410-4650
Adresse
ONE MAIN STREET, CAMBRIDGE
Vergleichen Sie CGEM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CGEM
Cullinan Therapeutics Inc
|
7.81 | 511.58M | 0 | -153.16M | -134.48M | -3.69 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Cullinan Therapeutics Inc Stock (CGEM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-21 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-06-11 | Fortgesetzt | Stifel | Buy |
| 2024-10-24 | Eingeleitet | UBS | Buy |
| 2024-05-01 | Eingeleitet | Stifel | Buy |
| 2024-04-15 | Eingeleitet | William Blair | Outperform |
| 2024-02-15 | Eingeleitet | Wedbush | Outperform |
| 2023-06-15 | Eingeleitet | TD Cowen | Outperform |
| 2022-11-21 | Eingeleitet | BTIG Research | Buy |
| 2021-04-27 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-02-02 | Eingeleitet | Evercore ISI | Outperform |
| 2021-02-02 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-02-02 | Eingeleitet | SVB Leerink | Outperform |
| 2021-02-01 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Cullinan Therapeutics Inc Aktie (CGEM) Neueste Nachrichten
Cullinan Therapeutics (CGEM) Reveals Promising Phase 1 Data for CLN-049 in AML and MDS - GuruFocus
Cullinan Therapeutics Inc. stock daily chart insights2025 AllTime Highs & Free Technical Confirmation Trade Alerts - newser.com
Can Cullinan Therapeutics Inc. stock beat market expectations this quarterJuly 2025 Summary & Free Safe Entry Trade Signal Reports - newser.com
Cullinan Management Unveils Promising CLN-049 Clinical Data - TipRanks
Heatmap analysis for Cullinan Therapeutics Inc. and competitorsMarket Weekly Review & Verified Entry Point Signals - newser.com
Cullinan Therapeutics Presents New Data on CLN-049 at ASH Meeting - TradingView
Cullinan (NASDAQ: CGEM) announces 69% ORR for CLN-049 in r/r AML; Phase 1 shows manageable safety - Stock Titan
Cullinan Therapeutics Inc. stock trend forecastMarket Performance Summary & Weekly High Potential Alerts - newser.com
Can Cullinan Therapeutics Inc. stock attract ESG capital inflowsQuarterly Performance Summary & Daily Market Momentum Tracking - newser.com
Using data filters to optimize entry into Cullinan Therapeutics Inc.Swing Trade & Technical Pattern Based Buy Signals - newser.com
Visual analytics tools that track Cullinan Therapeutics Inc. performanceWeekly Volume Report & Weekly Chart Analysis and Guides - newser.com
Cullinan Therapeutics Inc. stock outlook for YEARJuly 2025 Movers & High Conviction Trade Alerts - newser.com
Is Cullinan Therapeutics Inc. reversing from oversold territory2025 Bull vs Bear & Risk Controlled Stock Pick Alerts - newser.com
What machine learning models say about Cullinan Therapeutics Inc.2025 Top Decliners & Reliable Price Breakout Alerts - newser.com
Will Cullinan Therapeutics Inc. rebound enough to break evenWeekly Earnings Recap & Safe Entry Momentum Tips - newser.com
What makes Cullinan Therapeutics Inc. stock attractive to growth fundsQuarterly Profit Report & AI Driven Price Forecasts - newser.com
Backtesting results for Cullinan Therapeutics Inc. trading strategies2025 Volume Leaders & Real-Time Volume Analysis - newser.com
Why retail investors pile into Cullinan Therapeutics Inc. stockProduct Launch & Free Reliable Trade Execution Plans - newser.com
Will Cullinan Therapeutics Inc. stock gain from government policiesEarnings Overview Summary & Reliable Price Breakout Alerts - newser.com
Cullinan Therapeutics (NASDAQ:CGEM) Shares Up 13.5% After Insider Buying Activity - MarketBeat
Will Cullinan Therapeutics Inc. stock return to pre crisis levelsQuarterly Earnings Report & Verified Trade Idea Suggestions - newser.com
What momentum indicators show for Cullinan Therapeutics Inc. stockJuly 2025 Breakouts & AI Enhanced Trade Execution Alerts - newser.com
Cullinan Therapeutics (NASDAQ:CGEM) Major Shareholder Lynx1 Capital Management Lp Purchases 165,667 Shares - MarketBeat
Cullinan Therapeutics (CGEM) Projected to Post Earnings on Thursday - MarketBeat
Finanzdaten der Cullinan Therapeutics Inc-Aktie (CGEM)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):